Payne KD - Search Results

1

Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus.

Nguyen ST, Eaton SA, Bain AM, Rahman AP, Payne KD, Bedimo R, Herrington JD, Maclayton DO, Rodriguez-Barradas MC, Busti AJ. Nguyen ST, et al. Among authors: payne kd. Pharmacotherapy. 2008 Mar;28(3):323-30. doi: 10.1592/phco.28.3.323. Pharmacotherapy. 2008. PMID: 18294112

2

Safety and efficacy of simvastatin for the treatment of dyslipidemia in human immunodeficiency virus-infected patients receiving efavirenz-based highly active antiretroviral therapy.

Rahman AP, Eaton SA, Nguyen ST, Bain AM, Payne KD, Bedimo R, Busti AJ. Rahman AP, et al. Among authors: payne kd. Pharmacotherapy. 2008 Jul;28(7):913-9. doi: 10.1592/phco.28.7.913. Pharmacotherapy. 2008. PMID: 18576906

3

Multicenter evaluation of vancomycin dosing: emphasis on obesity.

Hall RG 2nd, Payne KD, Bain AM, Rahman AP, Nguyen ST, Eaton SA, Busti AJ, Vu SL, Bedimo R. Hall RG 2nd, et al. Among authors: payne kd. Am J Med. 2008 Jun;121(6):515-8. doi: 10.1016/j.amjmed.2008.01.046. Am J Med. 2008. PMID: 18501233 Free PMC article.

4

Dosing of antibacterial agents in obese adults: does one size fit all?

Payne KD, Hall RG 2nd. Payne KD, et al. Expert Rev Anti Infect Ther. 2014 Jul;12(7):829-54. doi: 10.1586/14787210.2014.912942. Epub 2014 May 8. Expert Rev Anti Infect Ther. 2014. PMID: 24809811 Review.

5

Dosing of antifungal agents in obese people.

Payne KD, Hall RG. Payne KD, et al. Expert Rev Anti Infect Ther. 2016;14(2):257-67. doi: 10.1586/14787210.2016.1128822. Epub 2015 Dec 28. Expert Rev Anti Infect Ther. 2016. PMID: 26641135 Review.

6

Dosing strategies to optimize currently available anti-MRSA treatment options (Part 2: PO options).

Payne KD, Das A, Ndiulor M, Hall RG 2nd. Payne KD, et al. Expert Rev Clin Pharmacol. 2018 Feb;11(2):139-149. doi: 10.1080/17512433.2018.1411800. Epub 2017 Dec 8. Expert Rev Clin Pharmacol. 2018. PMID: 29186999 Review.

7

Dosing strategies to optimize currently available anti-MRSA treatment options (Part 1: IV options).

Hall RG Nd, Thatcher M, Wei W, Varghese S, Varughese L, Ndiulor M, Payne KD. Hall RG Nd, et al. Among authors: payne kd. Expert Rev Clin Pharmacol. 2017 May;10(5):493-508. doi: 10.1080/17512433.2017.1300527. Epub 2017 Mar 15. Expert Rev Clin Pharmacol. 2017. PMID: 28293964 Review.

8

A standardized patient counseling rubric for a pharmaceutical care and communications course.

Horton N, Payne KD, Jernigan M, Frost J, Wise S, Klein M, Epps J, Anderson HG. Horton N, et al. Among authors: payne kd. Am J Pharm Educ. 2013 Sep 12;77(7):152. doi: 10.5688/ajpe777152. Am J Pharm Educ. 2013. PMID: 24052655 Free PMC article.

9

MRI of endocervicosis: an unusual cause of clustered periurethral cystic masses involving the bladder.

Eskridge MR, Rovner ES, Payne KD, Workman RB, Curry NS. Eskridge MR, et al. Among authors: payne kd. AJR Am J Roentgenol. 2007 Feb;188(2):W147-9. doi: 10.2214/AJR.05.1734. AJR Am J Roentgenol. 2007. PMID: 17242220 No abstract available.

10

Comparison of EDTA and Apo-Lactoferrin with Lysozyme on the Growth of Foodborne Pathogenic and Spoilage Bacteria.

Payne KD, Oliver SP, Davidson PM. Payne KD, et al. J Food Prot. 1994 Jan;57(1):62-65. doi: 10.4315/0362-028X-57.1.62. J Food Prot. 1994. PMID: 31113024 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters